Showing results (51-60 of 100) with videos related to
Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|November 3, 2009
Oseltamivir boosts 2009 H1N1 virus infectivity in vitroXiaojing Lin, Jianfang Zhou, Yonghui Zhang, et al.Journal of Medical Virology|June 17, 2024
Neutralizing antibody responses against contemporary and future influenza A(H3N2) viruses in paradoxical clades elicited by repeated and single vaccinationsTing Zhang, Yang Han, Weijuan Huang, et al.Biomolecules|October 26, 2024
A Novel Peptide from VP1 of EV-D68 Exhibits Broad-Spectrum Antiviral Activity Against Human EnterovirusesXiaojing Lin, Qiang Sun, Yang Cao, et al.The Journal of Infectious Diseases|June 3, 2006
Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza virusesJianfang Zhou, Helen K W Law, Chung Yan Cheung, et al.Antimicrobial Agents and Chemotherapy|December 25, 2013
A conformational restriction in the influenza A virus neuraminidase binding site by R152 results in a combinational effect of I222T and H274Y on oseltamivir resistanceLan Huang, Yang Cao, Jianfang Zhou, et al.The Journal of Infectious Diseases|March 7, 2006
Functional tumor necrosis factor-related apoptosis-inducing ligand production by avian influenza virus-infected macrophagesJianfang Zhou, Helen K W Law, Chung Yan Cheung, et al.Bioengineering (Basel, Switzerland)|November 24, 2022
Hand Exoskeleton Design and Human-Machine Interaction Strategies for RehabilitationKang Xia, Xianglei Chen, Xuedong Chang, et al.Virology Journal|September 17, 2013
Inactivation of the novel avian influenza A (H7N9) virus under physical conditions or chemical agents treatmentShumei Zou, Junfeng Guo, Rongbao Gao, et al.Viruses|March 28, 2024
Using an In Vivo Mouse Model to Determine the Exclusion Criteria of Preexisting Anti-AAV9 Neutralizing Antibody Titer of Pompe Disease Patients in Clinical TrialsHanqing Wang, Cengceng Zhang, Zheyue Dong, et al.Virology Journal|October 30, 2025
ARFGAP1 serves as a critical host factor during E30 infection: QS11 inhibits viral pathogenesis in hFcRn-IFNAR<sup>-/-</sup> miceJichen Li, Wei Duan, Ying Liu, et al.Pageof 10